Calix, Inc
CALX NYSE Communications Services, Nec Financials FY2016βFY2025
What Calix, Inc does
No business description yet.
- Legal name
- CALIX, INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 20, 2026
- Accession Β· CIK
- 0001406666-26-000005
0001406666
Revenue and margins
Calix, Inc had $1.0B of revenue in fiscal 2025, up 20.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $116M in fiscal 2025, 11.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Calix, Inc returned $93.6M to shareholders in fiscal 2025, 81% of free cash flow. The diluted share count rose 5.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Calix, Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $51.3M | $79.1M | $63.4M | $43.2M | $388M |
| Current ratio | 3.2x | 3.3x | 3.2x | 4.5x | 4.2x |
| Quick ratio | 2.5x | 2.4x | 2.5x | 3.7x | 3.4x |
| Total assets | $742M | $885M | $942M | $939M | $1.1B |
| Total liabilities | $174M | $205M | $223M | $158M | $199M |
| Shareholders' equity | $568M | $680M | $719M | $781M | $859M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 8 | 4 / 8 | 4 / 8 | 6 / 8 | 5 / 8 | 4 / 8 | 4 / 8 | 5 / 8 | 6 / 8 |
| Accruals ratio | β14.6% | β6.2% | β7.5% | β7.1% | β4.8% | 31.1% | 1.7% | β2.9% | β10.4% | β11.7% |
| Altman Z'' | β2.51 | β7.46 | β5.82 | β5.98 | 0.02 | 4.70 | 5.27 | 5.18 | 6.69 | 6.79 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $459M | $510M | $441M | $424M | $541M | $679M | $868M | $1.0B | $832M | $1.0B |
| Gross profit | $201M | $173M | $197M | $188M | $267M | $357M | $435M | $518M | $454M | $568M |
| Research and development | $107M | $128M | $90.0M | $81.2M | $85.3M | $102M | $132M | $178M | $180M | $190M |
| Operating income | β$28.1M | β$81.6M | β$18.5M | β$15.4M | $36.8M | $73.9M | $52.6M | $25.6M | β$43.0M | $21.0M |
| Interest expense | $0.6M | β | β | β | β | β | β | β | β | β |
| Pretax income | β$27.1M | β$81.8M | β$18.8M | β$16.5M | $34.3M | $72.7M | $54.0M | $34.8M | β$31.6M | $34.2M |
| Income tax | $0.3M | $1.2M | $0.5M | $1.2M | $0.8M | β$166M | $13.0M | $5.4M | β$1.9M | $16.3M |
| Net income | β$27.4M | β$83.0M | β$19.3M | β$17.7M | $33.5M | $238M | $41.0M | $29.3M | β$29.7M | $17.9M |
| Diluted EPS | β$0.56 | β$1.66 | β$0.37 | β$0.32 | $0.54 | $3.51 | $0.60 | $0.42 | β$0.45 | $0.26 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.06B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $24.4M | β$62.8M | $3.6M | $4.7M | $51.4M | $56.8M | $27.2M | $56.3M | $68.4M | $135M |
| Capital expenditure | $9.8M | $8.0M | $10.4M | $13.4M | $7.8M | $10.5M | $14.1M | $17.9M | $18.1M | $19.4M |
| Free cash flow | $14.6M | β$70.8M | β$6.9M | β$8.7M | $43.6M | $46.3M | $13.1M | $38.4M | $50.3M | $116M |
| Depreciation and amortization | $8.3M | $11.0M | $9.2M | $10.3M | $13.7M | $15.0M | $14.3M | $16.6M | $19.6M | $17.7M |
| Stock-based compensation | $14.3M | $12.4M | $17.5M | $11.2M | $14.0M | $24.2M | $44.8M | $62.8M | $70.8M | $87.9M |
| Share buybacks | $12.8M | $0.0M | $0.0M | β | β | $0.0M | $0.0M | $86.4M | $10.7M | $93.6M |
| Dividends and buybacks | $12.8M | $0.0M | $0.0M | β | β | $0.0M | $0.0M | $86.4M | $10.7M | $93.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $78.1M | $39.8M | $49.6M | $46.8M | $80.8M | $51.3M | $79.1M | $63.4M | $43.2M | $388M |
| Current assets | $219M | $162M | $175M | $144M | $267M | $409M | $547M | $598M | $585M | $692M |
| Current liabilities | $121M | $128M | $144M | $115M | $101M | $128M | $165M | $188M | $131M | $163M |
| Inventory | $44.5M | $31.5M | $50.2M | $40.2M | $52.3M | $88.9M | $149M | $133M | $103M | $134M |
| Property and equipment, net | $18.0M | $15.7M | $24.9M | $21.5M | $20.4M | $21.8M | $25.8M | $29.5M | $31.2M | $37.8M |
| Goodwill | $116M | $116M | $116M | $116M | $116M | $116M | $116M | $116M | $116M | $116M |
| Intangible assets | $0.8M | β | $0.0M | $12.1M | $9.5M | $6.9M | $4.3M | β | β | β |
| Total assets | $355M | $295M | $317M | $317M | $427M | $742M | $885M | $942M | $939M | $1.1B |
| Total liabilities | $143M | $150M | $165M | $163M | $147M | $174M | $205M | $223M | $158M | $199M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $213M | $145M | $152M | $154M | $280M | $568M | $680M | $719M | $781M | $859M |
| Margins | ||||||||||
| Gross margin | 43.9% | 33.9% | 44.7% | 44.3% | 49.3% | 52.5% | 50.2% | 49.9% | 54.6% | 56.8% |
| Operating margin | β6.1% | β16.0% | β4.2% | β3.6% | 6.8% | 10.9% | 6.1% | 2.5% | β5.2% | 2.1% |
| EBITDA margin | β4.3% | β13.8% | β2.1% | β1.2% | 9.3% | 13.1% | 7.7% | 4.1% | β2.8% | 3.9% |
| Net margin | β6.0% | β16.3% | β4.4% | β4.2% | 6.2% | 35.1% | 4.7% | 2.8% | β3.6% | 1.8% |
| FCF margin | 3.2% | β13.9% | β1.6% | β2.1% | 8.1% | 6.8% | 1.5% | 3.7% | 6.1% | 11.6% |
| Returns | ||||||||||
| Return on capital employed | β12.0% | β48.9% | β10.7% | β7.6% | 11.3% | 12.0% | 7.3% | 3.4% | β5.3% | 2.3% |
| Return on equity | β12.9% | β46.4% | β13.0% | β11.6% | 15.4% | 56.2% | 6.6% | 4.2% | β4.0% | 2.2% |
| Return on assets | β7.7% | β25.5% | β6.3% | β5.6% | 9.0% | 40.8% | 5.0% | 3.2% | β3.2% | 1.8% |
| Return on tangible equity | β28.6% | β288.4% | β54.0% | β68.8% | 21.7% | 53.5% | 7.3% | 4.9% | β4.5% | 2.4% |
| Growth | ||||||||||
| Revenue growth | β | 11.2% | β13.5% | β3.8% | 27.6% | 25.5% | 27.7% | 19.8% | β20.0% | 20.3% |
| Net income growth | β | β | β | β | β | 611.9% | β82.8% | β28.5% | β201.4% | β |
| EPS growth | β | β | β | β | β | 550.0% | β82.9% | β30.0% | β207.1% | β |
| FCF growth | β | β585.6% | β | β | β | 6.3% | β71.7% | 192.7% | 31.1% | 129.4% |
| Share count change | β | 2.9% | 4.9% | 4.5% | 12.7% | 9.4% | 1.6% | 0.6% | β5.0% | 5.2% |
| Financial health | ||||||||||
| Interest coverage | β48.1x | β | β | β | β | β | β | β | β | β |
| Current ratio | 1.8x | 1.3x | 1.2x | 1.2x | 2.6x | 3.2x | 3.3x | 3.2x | 4.5x | 4.2x |
| Quick ratio | 1.4x | 1.0x | 0.9x | 0.9x | 2.1x | 2.5x | 2.4x | 2.5x | 3.7x | 3.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.1% | 1.6% | 2.4% | 3.1% | 1.4% | 1.5% | 1.6% | 1.7% | 2.2% | 1.9% |
| Stock comp / revenue | 3.1% | 2.4% | 4.0% | 2.6% | 2.6% | 3.6% | 5.2% | 6.0% | 8.5% | 8.8% |
| Payouts / FCF | 87.9% | β | β | β | β | 0.0% | 0.0% | 225.0% | 21.2% | 81.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | 4.0 | 4.0 | 6.0 | 5.0 | 4.0 | 4.0 | 5.0 | 6.0 |
| Altman Z'' | β2.5 | β7.5 | β5.8 | β6.0 | 0.0 | 4.7 | 5.3 | 5.2 | 6.7 | 6.8 |
| Accruals ratio | β14.6% | β6.2% | β7.5% | β7.1% | β4.8% | 31.1% | 1.7% | β2.9% | β10.4% | β11.7% |
Source: SEC EDGAR XBRL filings (CIK 0001406666). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.